Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 2, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mike Matson Reiterated (SRDX) at Strong Buy with Increased Target to $50 on, Aug 2nd, 2023
Mike Matson of Needham, Reiterated "Surmodics, Inc." (SRDX) at Strong Buy with Increased Target from $36 to $50 on, Aug 2nd, 2023.
Mike has made no other calls on SRDX in the last 4 months.
There is 1 other peer that has a rating on SRDX. Out of the 1 peers that are also analyzing SRDX, 0 agree with Mike's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mike
- Michael Petusky of "Barrington Research" Maintained at Buy with Increased Target to $69 on, Wednesday, June 21st, 2023
